Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: mtconway who wrote (82894)	2/15/2000 3:32:00 AM
From: Jenna	Read Replies (1) \| Respond to of 120523

Stocks that should move tomorrow: TEVA, MERQ, ORCT, and FORTY.. There are more but that's enough for now. All are repeaters and some of the better plays. This kind of updates will be on the Market Gems Bulletin board come March. It is infinitely more lucrative to be familiar with the stocks you are trading than buying 'one day wonders' on news or unsupported claims on momentum stocks. I will be putting over 100 of our best plays into a database for watching news that might come out. Formula delaying earnings release By Jerusalem Post Staff (February 15) - Formula Systems Ltd., a software holding company, said yesterday it is postponing release of its fourth-quarter earnings results until February 28, because of the planned public offering by its Magic Software Enterprises subsidiary. "According to the information currently available... the earnings per share for Formula Systems Ltd. is expected to be higher than analyst and Wall Street expectations," the company said in a statement. Formula's Nasdaq-traded shares were up 13.85 to $76.25 at midday yesterday. *FOCUS-Teva Q4 EPS jump, sets stock split (New throughout) By Tova Cohen TEL AVIV, Feb 14 (Reuters) - Teva Pharmaceutical Industries (NasdaqNM:TEVA - news) announced on Monday a 25.5 percent rise in fourth quarter 1999 earnings per share and said it was ''very comfortable'' with a $2.60 EPS consensus estimate for 2000. ''We are very comfortable with the (2000) consensus estimate,'' CFO Dan Suesskind told a results news conference. Israel's biggest drug company also said its board had approved a two-for-one stock split of its ordinary shares to be carried out in the form of a 100 percent stock dividend. The market welcomed the news and Teva's Tel Aviv traded shares gained 4.75 percent at 309.0 shekels on the news in early afternoon as the Tel Aviv 25 blue chip index was up 0.12 percent. ***************** techstocks.com techstocks.com techstocks.com